Quiz-summary
0 of 10 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
Information
Level 1 MCQ Description
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
0 of 10 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 points, (0)
| Average score |
|
| Your score |
|
Categories
- Not categorized 0%
- Deep vein thrombosis 0%
-
Here are the results
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Answered
- Review
-
Question 1 of 10
1. Question
1 points1 which of the following are the symptoms of DVT
I Edema
II Leg pain
III TendernessCorrect
Incorrect
-
Question 2 of 10
2. Question
1 points2 Potential complications of DVT include the following
I heart failure
II Postthrombotic syndrome (PTS)
III Paradoxic emboliCorrect
Incorrect
-
Question 3 of 10
3. Question
1 points3 Treatment options for DVT include the following:
I Anticoagulation
II Pharmacologic thrombolysis
III elastic compression stockings and ambulationCorrect
Incorrect
-
Question 4 of 10
4. Question
1 points4 Heparin products used in the treatment of DVT include the following
I enoxaparin
II UFH
III FondaparinuxCorrect
Incorrect
-
Question 5 of 10
5. Question
1 points5 Factor Xa inhibitors used in the treatment of DVT include the following:
I enoxaparin
II Fondaparinux
III RivaroxabanCorrect
Incorrect
-
Question 6 of 10
6. Question
1 points6 which of the following are true about the Anticoagulant therapy for DVT
I it does not remove the thrombus
II it is noninvasive
III low risk of complicationsCorrect
Incorrect
-
Question 7 of 10
7. Question
1 points7 which of the following drug exert their anticoagulant effect by inhibiting the activity of activated factor X.
I Fondaparinux
II enoxaparin
III HeparinCorrect
Incorrect
-
Question 8 of 10
8. Question
1 points8 Fondaparinux acts by
I by inhibiting the activity of activated factor X.
II selective inhibition of factor Xa,
III by inhibiting the activity of activated antithrombinCorrect
Incorrect
-
Question 9 of 10
9. Question
1 points9 which of the following are Factor Xa and Direct Thrombin Inhibitors
I Apixaban
II Rivaroxaban
III DabigatranCorrect
Incorrect
-
Question 10 of 10
10. Question
1 points10 which of the following are the indications of Dabigatran
I reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
II treatment of DVT and PE in patients who have been treated with a parenteral anticoagulant for 5-10 days
III reduce the risk of DVT and PE recurrence in patients who have been previously treatedCorrect
Incorrect